Skip to main content
Back to Show
PBS News Hour

What’s keeping biosimilar drugs from the U.S. market?

NewsHour looks at a revolutionary class of drugs called "biologics." Americans have been paying more for their benefits than patients in Europe or Asia some say, because the "generic" versions or "biosimilars" have not hit the U.S. market. Dr. Emily Senay looks into why there's a delay and when American consumers can expect discounts.

Support Provided By
Season
September 6, 2025 - PBS News Weekend full episode
26:45
September 6, 2025 - PBS News Weekend full episode
September 5, 2025 - PBS News Hour full episode
57:46
September 5, 2025 - PBS News Hour full episode
September 4, 2025 - PBS News Hour full episode
57:46
September 4, 2025 - PBS News Hour full episode
September 3, 2025 - PBS News Hour full episode
57:46
September 3, 2025 - PBS News Hour full episode
September 2, 2025 - PBS News Hour full episode
57:46
September 2, 2025 - PBS News Hour full episode
September 1, 2025 - PBS News Hour full episode
57:46
September 1, 2025 - PBS News Hour full episode
August 31, 2025 - PBS News Weekend full episode
26:45
August 31, 2025 - PBS News Weekend full episode
August 30, 2025 - PBS News Weekend full episode
26:45
August 30, 2025 - PBS News Weekend full episode
August 29, 2025 - PBS News Hour full episode
57:46
August 29, 2025 - PBS News Hour full episode
August 28, 2025 - PBS News Hour full episode
57:46
August 28, 2025 - PBS News Hour full episode
August 27, 2025 - PBS News Hour full episode
57:46
August 27, 2025 - PBS News Hour full episode
August 26, 2025 - PBS News Hour full episode
57:46
August 26, 2025 - PBS News Hour full episode
Active loading indicator